NORMAL SITUATION

ANTIGON

Financial year 2021 · closed on 31/12/2021
Net result
-699,5 k €
-130.3% YoY
Gross margin
-171,6 k €
-90.0% YoY
Equity
1,6 M €
+325.9% YoY
Workforce
2,5 ETP

Company — Normal situation.

What does ANTIGON do?

ANTIGON is a company registered in Belgium. It employs on average 2,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0658.877.151
Legal form
Public limited company
Contributed capital
3 272 637,50 €
Latest accounts
31/12/2021
Average workforce
2,5 ETP
Joint committees (2)
  • 116
  • 207
Signals
Solid equityGood liquidityPositive cashflowHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202120182017
Income statement
Gross margin-171,6 k €-90,3 k €-168,3 k €
EBITDA-310,1 k €-90,7 k €-169,1 k €
Operating result-1,1 M €-397,2 k €-429 k €
Net result-699,5 k €-303,8 k €-272,4 k €
Balance sheet
Equity1,6 M €382,4 k €657,9 k €
Total assets2,6 M €996,5 k €1,3 M €
Cash155,4 k €187,7 k €737,5 k €
Debts974,8 k €613,5 k €667,4 k €
Other
Workforce2,5 ETP
Governance

Board of directors

Seen on filing of 31/12/2021 · 6 active · 8 ended

Active mandates

THOMAS LIENARD

Director · since 01 juillet 2020 · until 01 juillet 2026 · 0641.918.779

Represented by Thomas Lienard

Active
THEODORUS III

Director · since 26 juin 2020 · until 14 juin 2022 · 0535.803.353

Represented by Alexandre Jouve

Active
SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 28 février 2019 · until 14 juin 2022 · 0884.341.575

Represented by Helena POZIOS

Active
BT LIFE SCIENCE

Managing director · since 11 juillet 2016 · until 14 juin 2022 · 0550.441.049

Represented by Thierry BALTUS

Active
PHARBIOMED

Director · since 11 juillet 2016 · until 14 juin 2022 · 0597.824.559

Represented by Hanane EL KENZ

Active
Terry MORO

Director · since 11 juillet 2016 · until 14 juin 2022

Active

Ended mandates

SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 17 février 2018 · until 14 juin 2022 · 0884.341.575

Represented by Carsten Engel

Ended
SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 17 février 2018 · until 28 février 2019 · 0884.341.575

Represented by Engel CARSTEN

Ended
Alexandre CHAU

Director · since 27 avril 2017 · until 14 juin 2022

Ended
BT LIFE SCIENCE

Managing director · since 11 juillet 2016 · until 14 juin 2022 · 0550.441.049

Represented by Thierry Baltus

Ended
Annual accounts

Full financial information

20212020201920182017
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202101/01/202001/01/201901/01/201811/07/2016
Closing of the financial year31/12/202131/12/202031/12/201931/12/201831/12/2017
Length of the financial year12 months12 months12 months12 months18 months
Filing date14/07/202206/09/202127/08/202017/07/201917/07/2018
General meeting30/06/202230/06/202126/06/202012/07/201928/06/2018
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202130/06/202214/07/2022FrenchPDF
Abridged model31/12/202030/06/202106/09/2021FrenchPDF
Abridged model31/12/201926/06/202027/08/2020FrenchPDF
Abridged model31/12/201812/07/201917/07/2019FrenchPDF
Abridged model31/12/201728/06/201817/07/2018FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 6 active · 8 ended

Active mandates

THOMAS LIENARD

Director · since 01 juillet 2020 · until 01 juillet 2026 · 0641.918.779

Represented by Thomas Lienard

Active
THEODORUS III

Director · since 26 juin 2020 · until 14 juin 2022 · 0535.803.353

Represented by Alexandre Jouve

Active
SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 28 février 2019 · until 14 juin 2022 · 0884.341.575

Represented by Helena POZIOS

Active
BT LIFE SCIENCE

Managing director · since 11 juillet 2016 · until 14 juin 2022 · 0550.441.049

Represented by Thierry BALTUS

Active
PHARBIOMED

Director · since 11 juillet 2016 · until 14 juin 2022 · 0597.824.559

Represented by Hanane EL KENZ

Active
Terry MORO

Director · since 11 juillet 2016 · until 14 juin 2022

Active

Ended mandates

SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 17 février 2018 · until 14 juin 2022 · 0884.341.575

Represented by Carsten Engel

Ended
SAMBRINVEST SPIN-OFF/SPIN-OUT

Director · since 17 février 2018 · until 28 février 2019 · 0884.341.575

Represented by Engel CARSTEN

Ended
Alexandre CHAU

Director · since 27 avril 2017 · until 14 juin 2022

Ended
BT LIFE SCIENCE

Managing director · since 11 juillet 2016 · until 14 juin 2022 · 0550.441.049

Represented by Thierry Baltus

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates09/12/2022
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2021
    Annual accounts 2021-699,5 k €
  2. 2018
    Annual accounts 2018-303,8 k €
  3. 2017
    Annual accounts 2017-272,4 k €